Search Results for

Medicine by the numbers

176-200 of 632 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Joint Letter Opposing Efforts to Repeal the Individual Mandate - November 14, 2017

...that would stabilize the insurance market, has the potential, to raise health insurance premiums by a projected 20 percent and increase the number of uninsured Americans. ### About the American Academy of Family Physicians Founded in 1947, the AAFP represents 129,000...

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/coverage/aca/ST-IndividualMandateRepeal-SenateTaxReform-111417.pdf

Joint Letter to Senate Finance Committee on Medicare Appropriate Use Criteria - ...

Joint letter to Congress from societies whose members frequently order and rely on advanced diagnostic imaging for the diagnosis and treatment of their patients expressing deep concern with the timeline for implementation of the Medicare Appropriate Use Criteria

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/health_it/interoperability/LT-SFC-AUC-092815.pdf

LT-VAConfCommittee-062314

AAFP Letter to the Committee of Veterans Affairs applauding the passage of Veterans’ Access to Care through Choice, Accountability, and Transparency Act

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/workforce/scope/LT-VAConfCom-062314.pdf

President's FY 2008 Budget

Executive Summary of the President's FY 2008 Budget

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/coverage/aca/ES-FY2008budget-021407.pdf

H1N1

Testimony to the Committee on Small Business regarding the Potential Adverse Effects of H1N1 on the Economy

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/prevention/vaccines/TS-SmallBusinessCommittee-TestimonyonH1N1-090909.pdf

Transparency Reports

Letter to CMS on the Proposed Transparency Reports and Reporting of Physician Ownership or Investment Interests

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/legal/sunshine/LT-CMS-Transparency-020812.pdf

Youth Prevention and Tobacco Harm Reduction Act

Letter to House Regarding Opposition to the Youth Prevention and Tobacco Harm Reduction Act (H.R. 1261)

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/prevention/tobacco/LT-Representative-OppositiontoYouthPreventionandTobaccoHarmReductionActHR1261-032609.pdf

TS-Appropriations-DeptLaborHHSFunding-032714.pdf

On March 28, 2013, the AAFP submitted testimony to the House Committee on Appropriations to inform them of our funding priorities for fiscal year 2015. The AAFP urged the House Appropriations Subcommittee on Labor, Health and Human Services, and Education to invest in our nation’s ...

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/workforce/title-vii/TS-Appropriations-DeptLaborHHSFunding-032714.pdf

Joint Letter to CMS on E/M Policies in the 2019 Proposed Medicare Physician Fee ...

...patients down to two each, the undersigned organizations believe there are a number of unanswered questions and potential unintended consequences that would result from the coding policies in the proposed rule. We oppose the implementation of this proposal because it could hurt...

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/payment/medicare/LT-CMS-EMSignOn-082718.pdf

AAFP Letter to the FDA on the MRTPAs for IQOS System - December 20, 2017

...cause of death and illness in our nation. Annually, more than 480,000 people die from tobacco use and secondhand smoke; greater than the number of deaths caused by HIV/AIDS, alcohol, automobile accidents, murder, suicide, drugs and fires combined. Each year, smoking related illness...

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/prevention/tobacco/LT-FDA-Tobacco-122017.pdf

Electronic Prescriptions for Controlled Substances 2010

Joint Letter to the DEA regarding Electronic Prescriptions for Controlled Substances

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/health_it/prescribing/LT-Leonhart-DEALetter-052610.pdf

Letter to CMMS - Medicare Advantage and Medicare Rx Drug Benefit Programs

Letter to Charlene Frizzera regarding CMS-4085-P; Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/payment/medicare/LT-Frizzera-MedicareAdvantageandPrescriptionDrugBenefitPrograms-120809.pdf

Letter to HHS Expressing Concern Over EHR Incentive Program

Statement to the Subcommittee on Government Management, Organization and Procurement Concerning HIT and Underserved Areas

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/health_it/emr/TS-SubcommitGovtManagement-ConcerningHITandUnderservedAreas-110107.pdf

AAFP Response to the HHS Draft Report on Pain Management - April 1, 2019

...While our currently fragmented health care system is not well-prepared to address these interrelated issues, the specialty of family medicine is suited for this task. The AAFP is actively engaged in the national discussion on pain management and opioid misuse. Committed to ensuring...

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/prevention/risk/LT-HHS-PainManagement-040119.pdf

AAFP Letter to CMS Regarding the Request for Information on CLIA - March 6, 2018

...the most important nonwaived, regulated analytes are being included in a regulated PT program. The market is currently flooded with a large number of waived testing methods and point-of-care devices available on the market. Proper oversight and testing of these devices is currently...

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/health_it/emr/LT-CMS-CLIA-030618.pdf

Joint Letter to USP with Concerns About the Potential Impact of a Revised Chapter 797

...number of comments received on the proposed revisions to items such as Chapter 797. However, the physician community continues to have concerns about the potential impact of a revised Chapter 797 on physician practices and patient access to critical sterile drug products....

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/legal/administrative/LT-USP-092717.pdf

AAFP Letter to the FDA on Establishing a Nicotine Standard - June 20, 2018

...Every day, family physicians see the devastating impact that smoking has on our patients. We welcome the FDA’s commitment to reducing the number of Americans who smoke, thereby improving their health. Although most tobacco-related diseases are not caused by nicotine, the addictive...

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/prevention/tobacco/LT-FDA-NicotineStandards-062018.pdf

AAFP Letter to HHS on 2016 Notice of Benefit and Payment Parameters - December 18, 2014

AAFP response to the proposed rule titled, HHS Notice of Benefit and Payment Parameters for 2016 which makes adjustments to federally facilitated exchanges.

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/coverage/aca/LT-HHS-BenefitPaymetParameter0121814.pdf

AAFP Letter to CMS on Final Medicare Physician Fee Schedule

AAFP response letter to Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule final rule with comment period

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/payment/medicare/feesched/LT-CMS-FinalMedicarePhysicianFeeSchedule-012314.pdf

Primary Care Training

Primary Care Training: A Vital Plank in the Health Reform Platform

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/workforce/title-vii/ES-Care-Platform-0310.pdf

AAFP Letter to Senate HELP on Mental Health Priorities - March 16, 2016

The AAFP comments on key primary care priorities for mental health reform.

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/prevention/strategy/LT-HELP-MentalHealth-031616.pdf

AAPF Letter to Ways and Means on Stark Law and MACRA

AAFP response to a request for information from the Senate Finance and House Ways and Means Committees, on the topic of what modifications to the Stark Law are needed for MACRA implementation.

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/payment/medicare/LT-WaysandMeans-StarkLaw-020516.pdf

Dangers of Tobacco

Joint Letter on HHS Media Campaign on the Dangers of Tobacco

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/prevention/tobacco/LT-Sebelius-HHSMediaCampaignonDangersofTobacco-032012.pdf

AAFP Letter to the FDA on Nicotine Flavors - June 20, 2018

...addiction to tobacco products, curb spending due to tobacco-related illnesses, and reduce the overall number of long-term tobacco users. Regulating flavors could also decrease the number of individuals living with chronic illness due to tobacco use and ultimately reduce the...

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/prevention/tobacco/LT-FDA-NicotineProductFlavors-062018.pdf

Health Education Spending

Coalition Letter to the Senate on Health Education Spending

Advocacy

https://www.aafp.org/dam/AAFP/documents/advocacy/workforce/title-vii/LT-Education-Spending-051410.pdf

Page  Prev 4 5 6 7 8 9 10 11 12 13 Next

25 50 100 results per page